Serum Protein profile in IPMN

Objectives The incidence of intraductal papillary mucinous neoplasm (IPMN) is increasing and thereby the number of patients under surveillance. There is a need for easily available serum biomarkers to distinguish patients with low or moderate grade dysplasia from those with high grade dysplasia or IPMN-associated cancer needing surgery.

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Heini Nieminen, Mayank Saraswat, Sakari Joenv äärä, Ari Ristimäki, Hanna Seppänen, Caj Haglund, Risto Renkonen Tags: 7. Cystic lesions of the pancreas Source Type: research